Charles M. Clark, MD
Clark C.; The National Diabetes Education Program: Changing the Way Diabetes Is Treated. Ann Intern Med. 1999;130:324-326. doi: 10.7326/0003-4819-130-4-199902160-00020
Download citation file:
Published: Ann Intern Med. 1999;130(4_Part_1):324-326.
The past few years have been exciting for those of us who treat persons with diabetes. After decades of debate, the evidence that diabetes treatment can prevent or markedly reduce many of the long-term complications of the disease has now become overwhelming. Recent epidemiologic and prospective therapeutic trials examining this hypothesis have found that glycemic control will reduce the microvascular complications of diabetes in patients with either type of the disease (Table). The pivotal trial for patients with type 1 diabetes was the Diabetes Control and Complications Trial, a 10-year trial that was reported in 1993 and sponsored by the National Institutes of Health (1). This trial showed that for every 10% reduction in hemoglobin A1c, a corresponding 40% reduction occurred in the rate of retinopathy; similar reductions were also found in the rates of nephropathy and neuropathy.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Endocrine and Metabolism, Diabetes, Coronary Risk Factors.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only